Zhejiang Hisoar Pharmaceutical Co. Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisoar Pharmaceutical Co. Ltd with three other
companies in this sector in China:
Xiangxue Pharmaceutical Co Ltd
sales of 2.19 billion Chinese Renmimbi [US$347.41 million]
of which 37%
was Chinese Herbal Medicines),
Guizhou Bailing Group Pharmaceutical Company Limited
(2.59 billion Chinese Renmimbi [US$411.66 million]
of which 91%
was Industry), and
Guangxi Wuzhou Zhongheng Group, Ltd.
(2.05 billion Chinese Renmimbi [US$325.02 million]
of which 93%
was Pharmaceutical Segment).
Zhejiang Hisoar Pharmaceutical Co. Ltd reported sales of 2.31 billion Chinese Renmimbi (US$366.73 million)
December of 2017.
decrease of 5.1%
versus 2016, when the company's sales were 2.43 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 10.7% decline
in Dyes, from 1.20 billion Chinese Renmimbi to 1.08 billion Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Pharmatheutical Industry (up 2.7% to 1.29 billion Chinese Renmimbi)